Continuing Education Courses
Continuing Education for MLS & MLT
Continuing Education for Phlebotomists
Continuing Education for Histologists
HR Courses
Intro to the Medical Lab
Video Continuing Education Courses
All Available Courses
Exam Simulators
Exam Simulator for MLS & MLT
NSH + LabCE Histology Exam Simulator
Phlebotomy Exam Simulator
Molecular Exam Simulator
Case Simulators
RBC Morphology Simulator
White Blood Cell Differential Case Simulator
Advanced WBC Differential Case Simulator
Urinalysis Case Simulator
Body Fluid Case Simulator
Bacteriology Case Simulator
Blood Culture Gram Stain Case Simulator
LabCE Quiz Game
Contact & Support
Log In
Log In
Extended-Spectrum Beta-Lactamase (ESBL) Screening by Disk Diffusion
This version of the course is no longer available.
Need multiple seats for your university or lab?
Get a quote
The page below is a sample from the LabCE course
Case Studies in Clinical Microbiology
. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.
Learn more about Case Studies in Clinical Microbiology (online CE course)
Extended-Spectrum Beta-Lactamase (ESBL) Screening by Disk Diffusion
For initial screening of
K. pneumonia
,
K. oxytoca
, and
E. coli
by disk diffusion, CLSI proposes the use of cefpodoxime (10 µg), ceftazidime (30 µg), aztreonam (30 µg), cefotaxime (30 µg), or ceftriaxone (30 µg) discs. For
P. mirabilis
isolates, the use of cefpodoxime (10 µg), ceftazidime (30 µg), or cefotaxime (30 µg) is proposed. For screening purposes in all of these organisms, the use of more than one of these agents improves the sensitivity of detection.
If the isolates show the following zone sizes, it may indicate ESBL production and phenotypic confirmation should be performed. For
K. pneumonia
,
K. oxytoca
, and
E. coli
: cefpodoxime (≤ 17 mm), ceftazidime (≤ 22 mm), aztreonam (≤ 27 mm), cefotaxime (≤ 27 mm), or ceftriaxone (≤ 25 mm) For
P. mirabilis
: cefpodoxime (≤ 22 mm), ceftazidime (≤ 22 mm), or cefotaxime (≤ 27 mm).
X
×